Qure Ventures

Qure Ventures is Israel's first venture capital fund dedicated exclusively to digital health, founded in 2012 and headquartered in Herzliya. In November 2016 the firm launched a flagship $50 million vehicle in partnership with equity crowdfunding platform OurCrowd, sometimes branded as OurCrowd Qure. The fund invests predominantly in Israel-based digital health startups across Seed, Series A, and selective Series C follow-ons, with an explicit thesis to fund deep-tech solutions that improve patient care, reduce healthcare delivery costs, create data transparency, and empower health consumers. The fund is led by Managing Partners Dr. Yossi Bahagon — founder and CEO of Luminox Health, acquired by OurCrowd, and a recognized digital health expert — and Allen Kamer, co-founder of Humedica, which was acquired by UnitedHealth Group in 2013. Across 12 portfolio companies, notable names include Tyto Care (remote clinical exam kit), DarioHealth (IPO), Zebra Medical Vision (acquired by Nanox), and Carevive, which was acquired by Health Catalyst in June 2024. The portfolio has produced one IPO and three acquisitions in total. Qure's defining operating philosophy is hands-on engagement: roughly 70 percent of team time is devoted to supporting portfolio companies on strategy, business development, growth, and follow-on fundraising. Strategic partnerships spanning consumer, provider, payer, and pharma channels help portfolio companies access clinical-trial pipelines and commercial distribution faster than they could independently. This partnership-intensive model, combined with deep domain expertise in Israeli health technology, positions Qure as a category specialist in one of the world's leading digital health ecosystems.